Shingles clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
Zoster Eye Disease Study (ZEDS)
open to eligible people ages 18 years and up
This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.
San Francisco, California and other locations